Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Gasparini

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Cell Biology|May 26, 2004
Loss of Geminin induces rereplication in the presence of functional p53Marina Melixetian, Andrea Ballabeni, Laura Masiero, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
A novel t(2;3)(p11;q27) in a case of follicular lymphomaCinzia Tapinassi, Carla Micucci, Idoya Lahortiga, et al.
Genes, Chromosomes & Cancer|July 15, 2005
Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotypeTatiana Alessandra Gorletta, Patrizia Gasparini, Mario Milco D'Elios, et al.
The Lancet. Oncology|March 6, 2020
YOU<sup>TH</sup>: the sweatshirt collection created by adolescents with cancerElena Pagani Bagliacca, Matteo Silva, Laura Veneroni, et al.
Cancers|November 12, 2013
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileumMassimo Milione, Sara Pusceddu, Patrizia Gasparini, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2008
REGgamma proteasome activator is involved in the maintenance of chromosomal stabilityLaura Zannini, Daniele Lecis, Giacomo Buscemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumabAlessandra Magnifico, Luisa Albano, Stefano Campaner, et al.
Pediatric Blood & Cancer|September 7, 2020
Where are adolescents with cutaneous melanoma treated? An Italian nationwide study on referrals based on hospital discharge recordsAndrea Ferrari, Alice Bernasconi, Giovanna Sironi, et al.
Cells|February 20, 2020
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab TreatmentIlona Rybinska, Marco Sandri, Francesca Bianchi, et al.
Breast (Edinburgh, Scotland)|July 3, 2007
Relationship between p53 and p27 expression following HER2 signalingPatrizia Casalini, Marilena V Iorio, Valeria Berno, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Cell Biology|May 26, 2004
Loss of Geminin induces rereplication in the presence of functional p53Marina Melixetian, Andrea Ballabeni, Laura Masiero, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
A novel t(2;3)(p11;q27) in a case of follicular lymphomaCinzia Tapinassi, Carla Micucci, Idoya Lahortiga, et al.
Genes, Chromosomes & Cancer|July 15, 2005
Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotypeTatiana Alessandra Gorletta, Patrizia Gasparini, Mario Milco D'Elios, et al.
The Lancet. Oncology|March 6, 2020
YOU<sup>TH</sup>: the sweatshirt collection created by adolescents with cancerElena Pagani Bagliacca, Matteo Silva, Laura Veneroni, et al.
Cancers|November 12, 2013
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileumMassimo Milione, Sara Pusceddu, Patrizia Gasparini, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2008
REGgamma proteasome activator is involved in the maintenance of chromosomal stabilityLaura Zannini, Daniele Lecis, Giacomo Buscemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumabAlessandra Magnifico, Luisa Albano, Stefano Campaner, et al.
Pediatric Blood & Cancer|September 7, 2020
Where are adolescents with cutaneous melanoma treated? An Italian nationwide study on referrals based on hospital discharge recordsAndrea Ferrari, Alice Bernasconi, Giovanna Sironi, et al.
Cells|February 20, 2020
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab TreatmentIlona Rybinska, Marco Sandri, Francesca Bianchi, et al.
Breast (Edinburgh, Scotland)|July 3, 2007
Relationship between p53 and p27 expression following HER2 signalingPatrizia Casalini, Marilena V Iorio, Valeria Berno, et al.
Pageof 9